Sun Pharmaceutical Industries Ltd.

US Food and Drug Administration (USFDA) has issued Official Action Indicated (OAI) status to Sun Pharmaceutical Industries’ Dadra facility. USFDA conducted an inspection at Company’s Dadra facility from December 4, 2023 to December 15, 2023. The company will work with the regulator to achieve fully compliant status. 

Sun Pharmaceutical Industries is among the largest specialty generic pharmaceutical company and India's top pharmaceutical company.